Novel Approach to Amyloidosis Looks Promising (CME/CE)

(MedPage Today) -- An amyloidosis therapeutic strategy based on controlling gene expression passed a proof-of-concept test, suppressing transthyretin production in patients with transthyretin amyloidosis, investigators reported.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news